A placebo-controlled, ascending multiple-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of dapagliflozin in diabetic Japanese subjects

Trial Profile

A placebo-controlled, ascending multiple-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of dapagliflozin in diabetic Japanese subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2016

At a glance

  • Drugs Dapagliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms MAD
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 25 Jul 2008 Status changed from recruiting to completed, reported by ClinicalTrials.gov.
    • 09 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top